CRARX | CSZIX | CRARX / CSZIX | |
Total Expense Ratio | 0.83 | 0.75 | 111% |
Annual Report Gross Expense Ratio | 1.18 | 0.75 | 157% |
Fund Existence | 29 years | 11 years | - |
Gain YTD | 1.644 | 5.291 | 31% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 228M | 8.3B | 3% |
Annual Yield % from dividends | 2.29 | 2.55 | 90% |
Returns for 1 year | -6.87 | -3.83 | 179% |
Returns for 3 years | -18.61 | 12.64 | -147% |
Returns for 5 years | 9.88 | 36.37 | 27% |
Returns for 10 years | -29.04 | 75.62 | -38% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RLEOX | 12.73 | 0.04 | +0.32% |
Lazard Emerging Markets Core Equity R6 | |||
RGEBX | 83.86 | -0.14 | -0.17% |
American Funds Growth Fund of Amer R2E | |||
RICIX | 11.69 | -0.03 | -0.26% |
T. Rowe Price Intl Disciplined Eq I | |||
ASVNX | 9.32 | -0.10 | -1.06% |
American Century Small Cap Value C | |||
BOSOX | 17.52 | -0.27 | -1.52% |
Boston Trust Walden Small Cap |